Immune mechanisms leading to atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 112, Issue SUPPL. 6, 2003, Pages

  Novak, Natalija ^a   Bieber, Thomas ^a   Leung, Donald Y M ^b  

^a UNIVERSITY OF BONN   (Germany)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Atopic dermatitis; Dendritic cells; IgE; Inflammation; Skin

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR;

ANTIGEN PRESENTATION; ATOPIC DERMATITIS; CHROMOSOME 17Q; CHROMOSOME 1Q; CROHN DISEASE; DENDRITIC CELL; DERMATITIS; EOSINOPHIL; FOOD ALLERGY; FOOD INTAKE; GENETIC LINKAGE; HUMAN; INFLAMMATION; KERATINOCYTE; LYMPHOCYTE HOMING; MONOCYTE; PATCH TEST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSORIASIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN DISEASE; SKIN TEST; T LYMPHOCYTE SUBPOPULATION; TRANSCRIPTION REGULATION;

EID: 0345800718     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2003.09.032     Document Type: Article

References (140)

1. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003;112(suppl):S118-S127.
2. Leung DYM. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000;105:860-76.
3. Kay AB. Allergy and allergic diseases. First of two parts. N Engl J Med 2001;344:30-7.
4. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003;361:151-60.
5. Cantani A. Pathogenesis of atopic dermatitis (AD) and the role of allergic factors. Eur Rev Med Pharmacol Sci 2001;5:95-117.
6. Hanifin JM. Atopic dermatitis. J Allergy Clin Immunol 1984;73:211-26.
7. Wollenberg A, Kraft S, Oppel T, Bieber T. Atopic dermatitis: pathogenetic mechanisms. Clin Exp Dermatol 2000;25:530-4.
8. Wollenberg A, Bieber T. Atopic dermatitis: from the genes to skin lesions. Allergy 2000;55:205-13.
9. Novak N, Bieber T. Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 2000;12:252-62.
10. Hanifin JM. Atopiform dermatitis: do we need another confusing name for atopic dermatitis? Br J Dermatol 2002;147:430-2.
11. Schmid-Grendelmeier P, Simon D, Simon HU, Akdis CA, Wuthrich B. Epidemiology, clinical features, and immunology of the "intrinsic" (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis). Allergy 2001;56:841-9.
12. Schoneich JT, Wilkinson VL, Kado-Fong H, Presky DH, Kochan JP. Association of the human Fc epsilon RI gamma subunit with novel cell surface polypeptides. J Immunol 1992;148:2181-5.
13. Steinke JW, Borish L, Rosenwasser LJ. 5. Genetics of hypersensitivity. J Allergy Clin Immunol 2003;111:495-501.
14. Cookson WO. Genetic aspects of atopic allergy. Allergy 1998;53:9-14.
15. Lee YA, Wahn U, Kehrt R, et al. A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat Genet 2000;26:470-3.
16. Walley AJ, Chavanas S, Moffatt MF, et al. Gene polymorphism in Netherton and common atopic disease. Nat Genet 2001;29:175-8.
17. Tsunemi Y, Saeki H, Nakamura K, et al. Interleukin-13 gene polymorphism G4257A is associated with atopic dermatitis in Japanese patients. J Dermatol Sci 2002;30:100-7.
18. Tanaka K, Roberts MH, Yamamoto N, et al. Genetic variants of the receptors for thromboxane A2 and IL-4 in atopic dermatitis. Biochem Biophys Res Commun 2002;292:776-80.
19. Kaburagi Y, Shimada Y, Nagaoka T, Hasegawa M, Takehara K, Sato S. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res 2001;293:350-5.
20. Cookson WO, Ubhi B, Lawrence R, et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 2001;27:372-3.
21. Kabesch M, Peters W, Carr D, Leupold W, Weiland SK, von Mutius E. Association between polymorphisms in caspase recruitment domain containing protein 15 and allergy in two German populations. J Allergy Clin Immunol 2003;111:813-7.
22. Cookson WO, Young RP, Sandford AJ, et al. Maternal inheritance of atopic IgE responsiveness on chromosome 11q. Lancet 1992;340:381-4.
23. Smith SJ, Ying S, Meng Q, et al. Blood eosinophils from atopic donors 'express messenger RNA for the alpha, beta, and gamma subunits of the high-affinity IgE receptor (Fc epsilon RI) and intracellular, but not cell surface, alpha subunit protein. J Allergy Clin Immunol 2000;105:309-17.
24. Donnadieu E, Jouvin MH, Rana S, et al. Competing functions encoded in the allergy-associated F(c)epsilonRIbeta gene. Immunity 2003;18:665-74.
25. Kuster H, Thompson H, Kinet JP. Characterization and expression of the gene for the human Fc receptor gamma subunit. Definition of a new gene family. J Biol Chem 1990;265:6448-52.
26. Ring J, Kramer U, Schafer T, Behrendt H. Why are allergies increasing? Curr Opin Immunol 2001;13:701-8.
27. Bjorksten B. Perinatal events in relation to sensitization in the human. Am J Respir Crit Care Med 2000;162(suppl):S105-7.
28. Van Bever HP. Early events in atopy. Eur J Pediatr 2002;161:542-6.
29. Prescott SL, Macaubes C, Yabuhara A, et al. Developing patterns of T cell memory to environmental allergens in the first two years of life. Int Arch Allergy Immunol 1997;113:75-9.
30. Prescott SL, Macaubas C, Holt BJ, et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the th2 cytokine profile. J Immunol 1998;160;4730-7.
31. Prescott SL, Holt PG. Abnormalities in cord blood mononuclear cytokine production as a predictor of later atopic disease in childhood [editorial]. Clin Exp Allergy 1998;28:1313-6.
32. Lau S, Illi S, Sommerfeld C, et al. Early exposure to house-dust mite and cat allergens and development of childhood asthma: a cohort study. Multicentre Allergy Study Group. Lancet 2000;356:1392-7.
33. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357:1076-9.
34. Burks W. Skin manifestations of food allergy. Pediatrics 2003;111:1617-24.
35. Schade RP, Van Ieperen-Van Dijk AG, Versluis C, et al. Cell-surface expression of CD25, CD26, and CD30 by allergen-specific T cells is intrinsically different in cow's milk allergy. J Allergy Clin Immunol 2002;109:357-62.
36. Roehr CC, Reibel S, Ziegert M, Sommerfeld C, Wahn U, Niggemann B. Atopy patch tests, together with determination of specific IgE levels, reduce the need for oral food challenges in children with atopic dermatitis. J Allergy Clin Immunol 2001;107:548-53.
37. Niggemann B. The role of the atopy patch test (APT) in diagnosis of food allergy in infants and children with atopic dermatitis. Pediatr Allergy Immunol 2001;12:37-40.
38. Saarinen UM, Kajosaari M. Breastfeeding as prophylaxis against atopic disease: prospective follow-up study until 17 years old. Lancet 1995;346:1065-9.
39. Thijs C, Houwelingen A, Poorterman I, Mordant A, van den BP Essential fatty acids in breast milk of atopic mothers: comparison with non-atopic mothers, and effect of borage oil supplementation. Eur J Clin Nutr 2000;54:234-8.
40. Hattevig G, Kjellman B, Sigurs N, Grodzinsky E, Hed J, Bjorksten B. The effect of maternal avoidance of eggs, cow's milk, and fish during lactation on the development of IgE, IgG, and IgA antibodies in infants. J Allergy Clin Immunol 1990;85:108-15.
41. Tupker RA, De Monchy JG, Coenraads PJ, Homan A, van der Meer JB. Induction of atopic dermatitis by inhalation of house dust mite. J Allergy Clin Immunol 1996;97:1064-70.
42. Tan BB, Weald D, Strickland I, Friedmann PS. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 1996;347:15-8.
43. Riedler J, Braun-Fahrlander C, Eder W, et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 2001;358:1129-33.
44. Holt PG, Macaubas C. Development of long-term tolerance versus sensitisation to environmental allergens during the perinatal period. Curr Opin Immunol 1997;9:782-7.
45. Braun-Fahrlander C, Riedler J, Herz U, et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002;347:869-77.
46. Platts-Mills TA, Erwin EA, Allison AB, et al. The relevance of maternal immune responses to inhalant allergens to maternal symptoms, passive transfer to the infant, and development of antibodies in the first 2 years of life. J Allergy Clin Immunol 2003;111:123-30.
47. Novak N, Allam JP, Bieber T. Allergic hyperreactivity to microbial components: a trigger factor of "intrinsic" atopic dermatitis? J Allergy Clin Immunol 2003;112:215-6.
48. Langeveld-Wildschut EG, Riedl H, Thepen T, Bihari IC, Bruijnzeel PL, Bruijnzeel-Koomen CA. Modulation of the atopy patch test reaction by topical corticosteroids and tar. J Allergy Clin Immunol 2000;106:737-43.
49. Ring J, Darsow U, Behrendt H. Role of aeroallergens in atopic eczema: proof of concept with the atopy patch test. J Am Acad Dermatol 2001;45(suppl):S49-52.
50. Ring J, Darsow U, Gfesser M, Vieluf D. The 'atopy patch test' in evaluating the role of aeroallergens in atopic eczema. Int Arch Allergy Immunol 1997;113:379-83.
51. Kerschenlohr K, Decard S, Darsow U, Ollert M, Wollenberg A. Clinical and immunologic reactivity to aeroallergens in "intrinsic" atopic dermatitis patients. J Allergy Clin Immunol 2003;111:195-7.
52. Kerschenlohr K, Decard S, Przybilla B, Wollenberg A. Atopy patch test reactions show a rapid influx of inflammatory dendritic epidermal cells in patients with extrinsic atopic dermatitis and patients with intrinsic atopic dermatitis. J Allergy Clin Immunol 2003;111:869-74.
53. Tengvall LM, Johansson C, Scheynius A, Wahlgren C. Positive atopy patch test reactions to Pityrosporum orbiculare in atopic dermatitis patients. Clin Exp Allergy 2000;30:122-31.
54. Jamora MJ, Verallo-Rowell VM, Samson-Veneracion MT. Patch testing with 20% Dermatophagoides pteronyssinusl/farinae (Chemotechnique) antigen. Am J Contact Dermatol 2001;12:67-71.
55. Langeveld-Wildschut EG, Bruijnzeel PL, Mudde GC, et al. Clinical and immunologic variables in skin of patients with atopic eczema and either positive or negative atopy patch test reactions. J Allergy Clin Immunol 2000;105:1008-16.
56. Wistokat-Wulfing A, Schmidt P, Darsow U, Ring J, Kapp A, Werfel T. Atopy patch test reactions are associated with T lymphocyte-mediated allergen-specific immune responses in atopic dermatitis. Clin Exp Allergy 1999;29:513-21.
57. Darsow U, Vieluf D, Ring J. Evaluating the relevance of aeroallergen sensitization in atopic eczema with the atopy patch test: a randomized, double-blind multicenter study. Atopy Patch Test Study Group. J Am Acad Dermatol 1999;40:187-93.
58. Bos JD, Wierenga EA, Sillevis Smitt JH, van der Heijden FL, Kapsenberg ML. Immune dysregulation in atopic eczema. Arch Dermatol 1992;128:1509-12.
59. Novak N, Bieber T. The skin as a target for allergic diseases. Allergy 2000;55:103-7.
60. Fartasch M. Epidermal barrier in disorders of the skin. Microsc Res Tech 1997;38:361-72.
61. Pastore S, Mascia F, Giustizieri ML, Giannetti A, Girolomoni G. Pathogenetic mechanisms of atopic dermatitis. Arch Immunol Ther Exp (Warsz) 2000;48:497-504.
62. Di Nardo A, Wertz P, Giannetti A, Seidenari S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 1998:78:27-30.
63. Murata Y, Ogata J, Higaki Y, et al. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J Invest Dermatol 1996;106:1242-9.
64. Gfesser M, Rakoski J, Ring J. The disturbance of epidermal barrier function in atopy patch test reactions in atopic eczema. Br J Dermatol 1996;135:560-5.
65. Gfesser M, Abeck D, Rugemer J, et al. The early phase of epidermal barrier regeneration is faster in patients with atopic eczema. Dermatology 1997;195:332-6.
66. Giustizieri ML, Mascia F, Frezzolini A, et al. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 2001;107:871-7.
67. Girolomoni G, Pastore S. The role of keratinocytes in the pathogenesis of atopic dermatitis. J Am Acad Dermatol 2001;45(suppl):S25-8.
68. Pastore S, Fanales-Belasio E, Albanesi C, Chinni LM, Giannetti A, Girolomoni G. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J Clin Invest 1997;99:3009-17.
69. Mascia F, Mariant V, Girolomoni G, Pastore S. Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation. Am J Pathol 2003;163:303-12.
70. Soumelis V, Reche PA, Kanzler H, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002;3:673-80.
71. Toda M, Leung DY, Molet S. et al. Polarized in vivo expression of IL-11 and IL-17 between acule and chronic skin lesions. J Allergy Clin Immunol 2003;111:875-81.
72. Kakinuma T, Nakamura K, Wakugawa M, et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001;107:535-41.
73. Trautmann A, Akdis M, Blaser K, Akdis CA. Role of dysregulated apoptosis in atopic dermatitis. Apoptosis 2000;5:425-9.
74. Trautmann A, Akdis M, Kleemann D, et al. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 2000;106:25-35.
75. Trautmann A, Altznauer F, Akdis M, et al. The differential fate of cadherins during T-cell-induced keratinocyte apoptosis leads to spongiosis in eczematous dermatitis. J Invest Dermatol 2001;117:927-34.
76. Trautmann A, Akdis M, Brocker EB, Blaser K, Akdis CA. New insights into the role of T cells in atopic dermatitis and allergic contact dermatitis. Trends Immunol 2001;22:530-2.
77. Klunker S, Trautmann A, Akdis M, et al. A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFN-gamma-inducible alpha-chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis. J Immunol 2003;171:1078-84.
78. Trautmann A, Akdis M, Schmid-Grendelmeier P, et al. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. J Allergy Clin Immunol 2001;108:839-46.
79. Scheynius A, Johansson C, Buentke E, Zargari A, Linder MT. Atopic eczema/dermatitis syndrome and Malassezia. Int Arch Allergy Immunol 2002;127:161-9.
80. Leung DYM. Infection in atopic dermatitis. Curr Opin Pediatr 2003;15:399-404.
81. Cho SH, Strickland I, Boguniewicz M, et al. Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus auretis to atopic skin. J Allergy Clin Immunol 2001;108:269-74.
82. Gallo RL, Murakami M, Ohtake T, et al. Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol 2002;110:823-31.
83. Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-60.
84. Remitz A, Kyllonen H, Granlund H, Reitamo S. Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. J Allergy Clin Immunol 2001;107:196-7.
85. Laouini D, Kawamoto S, Yalcindag A, Mizoguchi E, Geha R. Epicutaneous sensitization with superantigen induces allergic skin inflammation. J Allergy Clin Immunol 2003;112:981-7.
86. Hauk PJ, Leung DY. Tacrolimus (FK506): new treatment approach in superantigen-associated diseases like atopic dermatitis? J Allergy Clin Immunol 2001;107:391-2.
87. Ochs RL, Muro Y, Si Y, Ge H, Chan EK, Tan EM. Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. J Allergy Clin Immunol 2000;105:1211-20.
88. Seiberler S, Natter S, Hufnagl P, Binder BR, Valenta R. Characterization of IgE-reactive autoantigens in atopic dermatitis. 2. A pilot study on IgE versus IgG subclass response and seasonal variation of IgE autoreactivity. Int Arch Allergy Immunol 1999;120:117-25.
89. Valenta R, Natter S, Seiberler S, et al. Autoallergy: a pathogenetic factor in atopic dermatitis? Curr Probl Dermatol 1999;28:45-50.
90. Valenta R, Natter S, Seiberler S, et al. Molecular characterization of an autoallergen, hom s 1, identified by serum ige from atopic dermatitis patients. J Invest Dermatol 1998;111:1178-83.
91. Mossabeb R, Seiberler S, Mittermann I, et al. Characterization of a novel isoform of alpha-nascent polypeptide-associated complex as IgE-defined autoantigen. J Invest Dermatol 2002;119:820-9.
92. Valenta R, Maurer D, Steiner R, et al. Immunoglobulin E response to human proteins in atopic patients. J Invest Dermatol 1996;107:203-8.
93. Kinaciyan T, Natter S, Kraft D, Stingl G, Valenta R. IgE autoantibodies monitored in a patient with atopic dermatitis under cyclosporin A treatment reflect tissue damage. J Allergy Clin Immunol 2002;109:717-9.
94. Schmid-Ott G, Jaeger B, Adamek C, et al. Levels of circulating CD8(+) T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis. J Allergy Clin Immunol 2001;107:171-7.
95. Lambert RW, Campion K, Ding W, Ozawa H, Granstein RD. Langerhans cell expression of neuropeptide Y and peptide YY. Neuropeptides 2002;36:246-51.
96. Carucci JA, Ignatius R, Wei Y, et al. Calcitonin gene-related peptide decreases expression of HLA-DR and CD86 by human dendritic cells and dampens dendritic cell-driven T cell-proliferative responses via the type I calcitonin gene-related peptide receptor. J Immunol 2000;164:3494-9.
97. Torii H, Tamaki K, Granstein RD. The effect of neuropeptides/hormones on Langerhans cells. J Dermatol Sci 1998;20:21-8.
98. Luger TA, Lotti T. Neuropeptides: role in inflammatory skin diseases. J Eur Acad Dermatol Venereol 1998;10:207-11.
99. Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002;147:71-9.
100. Asahina A, Hosoi J, Murphy GF, Granstein RD. Calcitonin gene-related peptide modulates Langerhans cell antigen-presenting function. Proc Assoc Am Physicians 1995;107:242-4.
101. Jarvikallio A, Harvima IT, Naukkarinen A. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 2003;295:2-7.
102. Seiffert K, Granstein RD. Neuropeptides and neuroendocrine hormones in ultraviolet radiation-induced immunosuppression. Methods 2002;28:97-103.
103. Novak N, Kraft S, Bieber T. IgE receptors. Curr Opin Immunol 2001;13:721-6.
104. Novak N, Kraft S, Bieber T. Unraveling the mission of FceRI on antigen-presenting cells. J Allergy Clin Immunol 2003;111:38-44.
105. Bieber T, de la Salle H, Wollenberg A, et al. Human epidermal langerhans cells express the high affinity receptor for immunoglobulin e (fc epsilon ri). J Exp Med 1992;175:1285-90.
106. Novak N, Bieber T, Katoh N. Engagement of fcepsilonri on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells. J Immunol 2001;167:797-804.
107. Von Bubnoff D, Matz H, Frahnert C, et al. FcepsilonRI induces the tryptophan degradation pathway involved in regulating T cell responses. J Immunol 2002;169:1810-6.
108. Hanifin JM, Chan SC. Monocyte phosphodiesterase abnormalities and dysregulation of lymphocyte function in atopic dermatitis. J Invest Dermatol 1995;105(suppl):84S-8S.
109. Holden CA, Chan SC, Hanifin JM. Monocyte localization of elevated cAMP phosphodiesterase activity in atopic dermatitis. J Invest Dermatol 1986;87:372-6.
110. Gantner F, Gotz C, Gekeler V, Schudt C, Wendel A, Hatzelmann A. Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferation. Br J Pharmacol 1998;123:1031-8.
111. Wang B, Rieger A, Kilgus O, et al. Epidermal langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI. J Exp Med 1992;175:1353-65.
112. Wollenberg A, Wen S, Bieber T. Phenotyping of epidermal dendritic cells: clinical applications of a flow cytometric micromethod. Cytometiy 1999;37:147-55.
113. Wollenberg A, Wen S, Bieber T. Langerhans cell phenotyping: a new tool for differential diagnosis of inflammatory skin diseases. Lancet 1995;346:1626-7.
114. Wellenberg A, Kraft S, Hanau D, Bieber T. Immunomorphological and ultrastructural characterization of langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol 1996;106:446-53.
115. Wollenberg A, Bieber T. Two populations of cd1a+epidermal dendritic cells expressing b7 molecules in human skin. Br J Dermatol 1998;138:358-9.
116. Wollenberg A, Mommaas M, Oppel T, Schottdorf EM, Gunther S, Moderer M. Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases. J Invest Dermatol 2002;118:327-34.
117. Oppel T, Schuller E, Gunther S, et al. Phenotyping of epidermal dendritic cells allows the differentiation between extrinsic and intrinsic forms of atopic dermatitis. Br J Dermatol 2000;143:1193-8.
118. Maurer D, Ebner C, Reininger B, Petzelbauer P, Fiebiger E, Stingl G. Mechanisms of fc epsilon ri-ige-facilitated allergen presentation by dendritic cells. Adv Exp Med Biol 1997;417:175-8.
119. Maurer D, Fiebiger E, Reininger B, et al. Fc epsilon receptor 1 on dendritic cells delivers ige-bound multivalent antigens into a cathepsin s-dependent pathway of mhc class ii presentation. J Immunol 1998;161:2731-9.
120. Novak N, Allam P, Geiger E, Bieber T. Characterization of monocyte subtypes in the allergic form of atopic eczema/dermatitis syndrome. Allergy 2002;57:931-5.
121. Novak N, Kraft S, Haberstok J, Geiger E, Allam P, Bieber T. A reducing microenvironment leads to the generation of FcepsilonRIhigh inflammatory dendritic epidermal cells (IDEC). J Invest Dermatol 2002;119:842-9.
122. Akdis M, Trautmann A, Klunker S, Blaser K, Akdis CA. Cytokine network and dysregulated apoptosis in atopic dermatitis. Acta Odontol Scand 2001;59:178-82.
123. Akdis M, Trautmann A, Blaser K, Akdis CA. T cells and effector mechanisms in the pathogenesis of atopic dermatitis. Curr Allergy Asthma Rep 2002;2:1-3.
124. Akdis M, Akdis CA, Weigl L, Disch R, Blaser K. Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA-memory T cells. J Immunol 1997;159:4611-9.
125. Homey B, Alenius H, Muller A, et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002;8:157-65.
126. Hwang ST. Mechanisms of T-cell homing to skin. Adv Dermatol 2001;17:211-41.
127. Hamid Q, Naseer T, Minshall EM, Song YL, Boguniewicz M, Leung DY. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 1996;98:225-31.
128. Messi M, Giacchetto I, Nagata K, Lanzavecchia A, Natoli G, Sallusto F. Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. Nat Immunol 2003;4:78-86.
129. Robinson DS, Lloyd CM. Asthma: T-bet - a master controller? Curr Biol 2002;12:R322-4.
130. Larche M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003;111:450-63.
131. Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 2002;295:338-42.
132. Afkarian M, Sedy JR, Yang J, et al. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat Immunol 2002;3:549-57.
133. Macaubas C, Lee PT, Smallacombe TB, et al. Reciprocal patterns of allergen-induced GATA-3 expression in peripheral blood mononuclear cells from atopies vs. non-atopies. Clin Exp Allergy 2002:32:97-106.
134. Breuer K, Kapp A, Werfel T. Urine eosinophil protein X (EPX) is an in vitro parameter of inflammation in atopic dermatitis of the adult age. Allergy 2001;56:780-4.
135. Wedi B, Raap U, Lewrick H, Kapp A. Delayed eosinophil programmed cell death in vitro: a common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis. J Allergy Clin Immunol 1997;100:536-43.
136. Hossny E, Aboul-Magd M, Bakr S. Increased plasma eotaxin in atopic dermatitis and acute urticaria in infants and children. Allergy 2001;56:996-1002.
137. Satoh T, Kaneko M, Wu MH, Yokozeki H, Nishioka K. Contribution of selectin ligands to eosinophil recruitment into the skin of patients with atopic dermatitis. Eur J Immunol 2002;32:1274-81.
138. Kay AB, Barata L, Meng Q, Durham SR, Ying S. Eosinophils and eosinophil-associated cytokines in allergic inflammation. Int Arch Allergy Immunol 1997:113:196-9.
139. Yawalkar N, Uguccioni M, Scharer J, et al. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 1999;13:43-8.
140. Boguniewicz M, Eichenfield LF, Hultsch T. Current management of atopic dermatitis and interruption of the atopic march. J Allergy Clin Immunol 2003;112(suppl):S140-S150.